Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

Journal: Cell

Published: 2020-08-05

DOI: 10.1016/j.cell.2020.08.001

Affiliations: 28

Authors: 71

Go to article
Institutions Share
Charité Department of Infectious Diseases and Pulmonary Medicine, Germany 0.24
Life and Medical Sciences Institute (LIMES), Uni Bonn, Germany 0.12
Platform for Single Cell Genomics and Epigenomics (PRECISE), Germany 0.09
Department of Internal Medicine I, Uni Bonn, Germany 0.08
Charité Institute for Medicial Immunology (IMI), Germany 0.06
Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Germany 0.06
Berlin Institute of Health (BIH), Germany 0.05
The German Center for Lung Research (DZL), Germany 0.04
Labor Berlin - Charité Vivantes GmbH, Germany 0.03
Berlin Institute for Medical Systems Biology (BIMSB), MDC, Germany 0.03
German Rheumatism Research Centre Berlin (DRFZ), Germany 0.03
Charité Institute of Virology, Germany 0.03
HZI-MHH Centre for Individualised Infection Medicine (CiiM), Germany 0.03
Twincore GmbH, Germany 0.03
Charité Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry (ILP), Germany 0.02
Genome Analytics Research Group (GMAK), HZI, Germany 0.01
German Center for Infection Research (DZIF), Germany 0.01
Radboud Center for Infectious Diseases (RCI), RU, Netherlands 0.01
Department of Internal Medicine, RU, Netherlands 0.01
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Germany 0.01
Bernhard Nocht Institute for Tropical Medicine (BNITM), Germany 0
Department of Internal Medicine, UHH, Germany 0